Background: Myofascial pain is an important cause of disability among the whole
population, and it is a common symptom of temporomandibular joint disorders (TMDs). Its …

Abstract Introduction Botulinum toxin‐A (BTX) is a potent neurotoxin that is emerging in the
scope of dental practice for its ability to temporarily paralyse musculature and reduce …

The masticatory system is a complex and highly organized group of structures, including
craniofacial bones (maxillae and mandible), muscles, teeth, joints, and neurovascular …

Mastication myalgia is the most common cause of non-odontogenic pain in the orofacial
region and is often associated with a reduced quality of life. The purpose of this review is to …

Background Botulinum toxin type A (BoNTA) injection into the masticatory muscles has been
widely used to treat a number of painful and nonpainful conditions; however, no systematic …

Background The unique anatomy of the Asian face, along with the influence of cultural
forces and regional preferences, has led to the development of specialized approaches to …

Objective The aim was to review the role of adjuvant therapies that may potentially
contribute toward the management of temporomandibular disorders (TMD). Methods The …

The physiological homeostasis of the masticatory complex in short-faced patients is too
robust to be disintegrated and reconstructed due to the powerful masseter muscle. This …

Background Clinical use of botulinum neurotoxins (BoNTs) in masticatory muscles is usually
bilateral, but most studies on the functional consequences of BoNT treatment have used …

Botulinum toxins for sleep bruxism - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …